Hypopituitarism as a rare complication of lung cancer immunotherapy

Jakub Krzysztof Gałązka, Anna Rudzińska, Grzegorz Rudzki, Katarzyna Szklener, Sławomir Mańdziuk

Vol 19, No 3 (2023)

Clinical vignette

Double hit — bispecific antibodies in cancer therapy

Alicja Bogdanowicz, Kamila Wojas-Krawczyk, Natalia Krzyżanowska, Paweł Krawczyk

Version of Record

Review paper

Do solitary pancreatic metastases of renal-cell carcinoma indicate an indolent disease with a strong indication for aggressive local treatment? A case report with literature review

Jolanta Dobrzańska, Paweł Potocki, Piotr J. Wysocki

Vol 20, No 1 (2024)

Case report

Two-center experience comparing the use of the FLOT4 and CROSS schemes for patients with gastric, esophageal, and gastroesophageal junction adenocarcinoma

Irene Solana López, David Gutiérrez Abad, Maria Victoria de Torres Olombrada, Elia Martínez Moreno, Ignacio Juez Martel, Alicia Hurtado Nuño, Ana Manuela Martín Fernández de Soignie, Carlos de Zea Luque, Nadia Sánchez Baños, Fátima Escalona Martín, Beatriz Losada Vila, Carmen Pantín González, Laura Rodríguez Lajusticia, Diego Malón Giménez, Beatriz Jiménez Munarriz, Roberto Hernández López, Julia Calzas Rodríguez, Juan Antonio Guerra Martínez

Vol 20, No 5 (2024)

Research paper

Vinorelbine plus platinum compared to vinorelbine plus capecitabine in treatment of patients with metastatic triple negative breast cancer previously treated with anthracycline and taxane: a prospective randomized study

Heba Mohamed El-Zawahry, Ayman Abd Al-Samie Gaber, Amany Abd-Elhameed Abou-Bakr, Marwa Nabil Abd-Elhafez, Ahmed Mohamed El-Debawy

Vol 20, No 1 (2024)

Research paper

Radiotherapy in patients with breast cancer and Li-Fraumeni syndrome — a narrative review

Joanna Huszno, Tomasz Rutkowski, Agata Roch-Zniszczoł, Rafał Stec

Version of Record

Review paper

Non-drug related costs of treatment with pertuzumab and trastuzumab in HER2-positive breast cancer patients in Poland

Michał Seweryn, Tomasz Banaś, Joanna Augustyńska, Agnieszka Leszczyńska, Paweł M. Potocki

Vol 20, No 3 (2024)

Research paper

Optimizing treatment strategies for a MET exon 14 skipping mutation in non-small-cell lung cancer: a case report of sequential immunotherapy and targeted therapy and literature review

Maria Grodkiewicz, Pawel Kozieł, Izabela Chmielewska, Anna Grenda, Paweł Krawczyk, Janusz Milanowski

Vol 19, No 6 (2023)

Case report

Novel biomarkers in bone sarcomas — diagnosis, treatment selection, and clinical trials

Anna M. Czarnecka, Piotr Błoński, Paulina Chmiel, Piotr Rutkowski

Version of Record

Review paper

Effects of the changes between preand post-treatment 18F-FDG PET-CT volumetric parameters on overall survival in pleural mesothelioma

Faris Tüzün, Senar Ebinç, Muhammet Ali Kaplan, İhsan Kaplan, Halil Kömek, Zeynep Oruç, Şadiye Kemal Tuzcu, Bekir Taşdemir

Vol 19, No 5 (2023)

Research paper

Trastuzumab deruxtecan in the treatment of adult patients with HER2-positive breast cancer

Joanna Kufel-Grabowska

Vol 19, No 5 (2023)

Review paper

Individualized surgical treatment in patients with advanced gastrointestinal stromal tumor — a case series

Jakub Pytlos, Jakub Pałucki, Małgorzata Lenarcik, Ireneusz Pierzankowski, Anna Klimczak, Tomasz Olesiński

Vol 19, No 5 (2023)

Case report

EGFR mutation and ALK fusion-positive non-small cell lung cancer: a multicenter prospective cohort study in Nagano Prefecture, Japan

Takashi Kobayashi, Shintaro Kanda, Kazunari Tateishi, Nobutoshi Morozumi, Ryouhei Yamamoto, Fumiaki Yoshiike, Hideaki Takizawa, Munetaka Takada, Manabu Yamamoto, Kenichi Nishie, Takasuna Keiichiro, Toshihiko Agatsuma, Mineyuki Hama, Hozumi Tanaka, Akemi Matsuo, Akio Morikawa, Masayuki Hanaoka, Tomonobu Koizumi

Vol 19, No 5 (2023)

Research paper

Combination of chemotherapy and endocrine treatment in breast cancer — is it still a taboo?

Piotr J. Wysocki

Vol 20, No 4 (2024)

Review paper

A case of pathologic complete response after neoadjuvant triplet chemotherapy for locally advanced colon cancer with mismatch repair enzyme proficiency

Mehmet Zahid Kocak, Murat Cakir, Ulku Kerimoglu, Murat Araz, Melek Karakurt Eryilmaz, Perran Fulden Yumuk, Mehmet Artac

Vol 19, No 2 (2023)

Case report

Gemcitabine-related fatal cholestatic hepatitis

Oguzhan Yildiz, Melek Karakurt Eryilmaz, Ali Fuat Gürbüz, Muzaffer Ugrakli, Seda Tas Ayçiçek, Murat Araz, Mehmet Artaç

Version of Record

Case report

Diagnosis and treatment of patients with breast cancer and mutation in the BRCA1/2 genes

Joanna Kufel-Grabowska, Bartosz Wasąg

Vol 20, No 3 (2024)

Review paper

Preventing 5-fluorouracil-induced ischemic events in very high-risk cardiac patients with documented ischemic heart disease: a retrospective cohort analysis

Ahmed Basuoni, Rami Abu Omar, Waleed DawaAlbeit, Ahmad Ghoche, Hasan Al-Sayegh, Issa AI Qarshoubi, Mansour Al-Moundhri

Vol 20, No 4 (2024)

Research paper

Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement

Artur Kowalik, Anita Chudecka-Głaz, Joanna Kufel-Grabowska, Iwona Skoneczna, Tomasz Kubiatowski

Vol 20, No 4 (2024)

Guidelines / Expert consensus

Malignant peripheral nerve sheath tumor—from genetics to multidisciplinary treatment

Anna M. Czarnecka, Paulina Chmiel, Paweł Sobczuk, Ewa Bartnik, Mateusz Spałek, Anna Szumera-Ciećkiewicz, Marcin Zdzienicki, Sławomir Falkowski, Piotr Rutkowski

Vol 21, No 1 (2025)

Review paper

Management of febrile neutropenia in a breast cancer patient with SARS-CoV-2 infection during dose-dense adjuvant chemotherapy

Joanna Terebińska, Robert Wojciechowski, Filip Zieliński, Anna Skrzypczyk-Ostaszewicz, Arkadiusz Zegadło, Emil Lisiak, Artur Maliborski, Renata Duchnowska

Vol 19, No 2 (2023)

Clinical vignette

Management of melanoma central nervous system metastases

Piotr Rutkowski, Dorota Kiprian, Tomasz Świtaj, Radosław Michalik, Mateusz Spałek, Katarzyna Kozak, Tomasz Mandat, Bożena Cybulska-Stopa, Monika Dudzisz-Śledź

Vol 20, No 3 (2024)

Guidelines / Expert consensus

The effect of different concentrations of anti-PD-1 and anti-PD-L1 antibodies on the activity of immune system cells in patients with non-small cell lung cancer

Aleksandra Bożyk, Kamila Wojas-Krawczyk, Marcin Nicoś, Paweł Krawczyk

Vol 20, No 2 (2024)

Research paper

Between “opioidophobia” and the opioid crisis: a cross-sectional comparison of opinions on opioid analgesic treatment between palliative care patients with cancer and physicians in Poland

Maria Wysocka, Anna Kieszkowska-Grudny, Jakub Klimkiewicz, Jerzy Jarosz, Martyna Hordowicz, Andrzej Silczuk, Tomasz Pasierski, Anna Klimkiewicz

Vol 20, No 5 (2024)

Research paper

Evaluating and minimising the psychological stress to enhance medication adherence among cancer patients by implementing integrative oncology techniques

Theivasigamani Kumutha, Kandappan Velavan, Govindaraj Saravanan, Lakshmanaperumal Padmashree, Balakrishnan Nandhinee Malar, Rajasekhar Harsha, Anuja S. Sasankan, K Akhil Krishna

Version of Record

Research paper